The Glow Stack: GHK-Cu, BPC-157, and TB-500 in Skin and Tissue Regeneration Research
The Glow Stack combines GHK-Cu, BPC-157, and TB-500—three peptides studied for skin regeneration, wound healing, and tissue repair. A review of the research on each component.
The "Glow Stack" is a community-coined term for a combination of three peptides — GHK-Cu (copper peptide), BPC-157, and TB-500 (Thymosin Beta-4) — that are individually studied for skin repair, wound healing, and soft tissue regeneration. The name reflects the skin-focused application most commonly discussed in research communities, though each component has a broader mechanistic profile.
This article reviews the research on each component separately and the mechanistic rationale for their combination. As with all peptide combinations discussed outside formal clinical trial settings, the evidence base for the stack as a whole is weaker than the evidence for individual components in isolation.
Component Overview
GHK-Cu (Copper Peptide)
GHK-Cu is a naturally occurring tripeptide — Gly-His-Lys — that forms a complex with copper (Cu²⁺). It was first isolated from human plasma and is also found in saliva and urine. Unlike the other two compounds in this stack, GHK-Cu is present endogenously and its plasma concentration declines with age, a factor that has driven research interest in supplementation.
Research has examined GHK-Cu's role in:
- Stimulating collagen and glycosaminoglycan synthesis in fibroblasts
- Upregulating genes associated with tissue remodeling (MMP and TIMP expression)
- Anti-inflammatory signaling through NF-κB pathway modulation
- Angiogenesis via VEGF upregulation in wound models
A 2018 review by Pickart and Margolina summarized the breadth of gene expression data associated with GHK-Cu, noting that it appears to modulate over 4,000 human genes — a finding from genomics analysis that the authors describe as consistent with a broad tissue-resetting or regenerative signaling role []. The scope of this claim warrants careful evaluation; gene expression modulation does not translate directly into predictable clinical outcomes.
For deeper coverage of GHK-Cu's mechanism, see Copper Peptides: GHK-Cu Research Overview.
BPC-157
BPC-157 is a synthetic 15-amino acid peptide derived from a protein found in human gastric juice. In animal models, it has been studied for accelerated tissue repair across multiple tissue types, including skin, tendon, muscle, and gut epithelium.
Mechanisms studied in the BPC-157 literature include nitric oxide pathway modulation, VEGF-mediated angiogenesis, and FAK-pathway signaling relevant to cell migration in healing tissue. In rodent wound models, BPC-157-treated animals showed accelerated healing timelines compared to controls in multiple published studies [].
In the context of the Glow Stack, BPC-157 contributes a wound healing and tissue integrity component that complements the collagen synthesis and extracellular matrix remodeling driven by GHK-Cu.
See BPC-157: Research and Mechanisms of Action for a full evidence review.
TB-500 (Thymosin Beta-4 Fragment)
TB-500 refers to a synthetic fragment of Thymosin Beta-4 (Tβ4), a naturally occurring 43-amino acid peptide that is one of the most abundant intracellular peptides in mammalian cells. The active region of Tβ4 responsible for many of its studied effects is the LKKTETQ sequence, which TB-500 is understood to correspond to.
Tβ4 / TB-500 has been studied for:
- Actin sequestration and regulation of cell migration
- Keratinocyte and endothelial cell migration in wound models
- Hair follicle stimulation in rodent studies
- Anti-inflammatory effects in cardiac and corneal injury models
A comprehensive review by Goldstein et al. outlines the multi-functional regenerative profile of Thymosin Beta-4, including its role in cell survival signaling, angiogenesis, and wound repair []. Some of this work — particularly corneal and cardiac injury models — has progressed to human clinical trials for specific indications, giving TB-500's parent molecule (Tβ4) a more developed clinical research profile than is typical for peptides in this space.
For full coverage of TB-500, see TB-500 and Thymosin Beta-4: Research Overview.
Mechanistic Rationale for the Combination
Each compound in the Glow Stack acts on partially overlapping but distinct aspects of tissue repair:
| Component | Primary Studied Mechanism | Tissue Focus |
|---|---|---|
| GHK-Cu | Collagen synthesis, ECM remodeling, anti-inflammatory | Dermis, connective tissue |
| BPC-157 | Angiogenesis, NO pathway, FAK signaling | Broad: skin, tendon, gut |
| TB-500 | Actin regulation, cell migration, keratinocyte activation | Skin epithelium, hair follicle |
The theoretical rationale for combining them is that they address different steps in the tissue repair cascade: GHK-Cu supports extracellular matrix quality, BPC-157 promotes vascular supply and inflammatory regulation, and TB-500 drives cellular migration and re-epithelialization. Whether these mechanisms are genuinely additive or synergistic in living tissue has not been tested in controlled combination studies.
Important Limitations
No combination trial data exists. The research cited above covers each compound individually. There are no published controlled trials examining the Glow Stack as a combined protocol. Claimed synergies are mechanistically plausible but unverified.
Most evidence is preclinical. The majority of the research on all three compounds comes from rodent models. Translating rodent wound healing outcomes to human skin outcomes is not straightforward, and results from animal studies frequently do not replicate in human trials.
Regulatory status of all three compounds. None of GHK-Cu (in injectable or peptide form), BPC-157, or TB-500 are approved pharmaceutical products for the applications discussed here. GHK-Cu is used in topical cosmetic formulations that operate under different regulatory standards than pharmaceutical-grade injectable research compounds.
Relationship to the KLOW Stack
The Glow Stack is a subset of the KLOW Stack, which adds KPV — a tripeptide with anti-inflammatory properties studied primarily in gut and systemic inflammation models — to create a broader anti-inflammatory and tissue repair protocol. Researchers interested in systemic inflammatory contexts alongside skin and connective tissue repair may find the extended stack's profile relevant.
For a framework on evaluating the quality of evidence behind any peptide combination, see Evaluating Peptide Research Claims.
References
- 1.Pickart L, Margolina A. “Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data.” International Journal of Molecular Sciences. 2018;19(7):1987. doi:10.3390/ijms19071987 [PubMed]
- 2.Gwyer D, Wragg NM, Wilson SL. “Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing.” Cell and Tissue Research. 2019;377(2):153-159. doi:10.1007/s00441-019-03016-8 [PubMed]
- 3.Goldstein AL, Hannappel E, Sosne G, Kleinman HK. “Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications.” Expert Opinion on Biological Therapy. 2012;12(1):37-51. doi:10.1517/14712598.2012.634793 [PubMed]